Thursday, September 17, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

Researchanti-vegfophthalmologydrug costs

Review compares anti-VEGF drug chemistry, costs and side effects

Journal of Medicine and Life authors assess chemical properties, pricing and adverse effects across anti-vascular endothelial growth factor medications.

PR
By Priya Raman · Science Reporter
Jun 30 20:00 ETSource: Journal of medicine and life

The wire

  1. 01Makhdoum and colleagues reviewed anti-VEGF medications across chemical properties, costs and side effects.
  2. 02Cost and safety differences drive prescribing in ophthalmology and oncology.
  3. 03The excerpt does not state which agents were favored.

From the source

Understanding anti-vascular endothelial growth factor medications: chemical properties, costs, and side effects

Journal of medicine and life · 2026 Jul · Makhdoum H, Alharbi A, Alhazmi S et al.

Read at pubmed.ncbi.nlm.nih.gov
Source URL https://pubmed.ncbi.nlm.nih.gov/42751623/